Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Electroacupuncture for CINV in Breast Cancer (ECO Study)
NCT06200168Phase 3Recruiting
- Start
- Jan 2024
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial (2 arms). Primary endpoint: Proportion of patients with no nausea during the overall stage at 120 hours. Started Jan 2024; status: recruiting.
Beyond the preview
Go deeper on NCT06200168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06200168.